PubRank

C Kamby

Author PubWeight™ 34.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999 8.44
2 Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2001 1.99
3 Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer 1999 1.55
4 Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol 1996 1.39
5 Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995 1.31
6 Aggressive fibromatosis. Surg Gynecol Obstet 1985 1.22
7 Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiother Oncol 1997 1.10
8 Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol Res Pract 1989 0.96
9 The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 1987 0.93
10 Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer. Cancer Chemother Pharmacol 2000 0.89
11 Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer 1987 0.85
12 Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract. Cancer 1994 0.85
13 Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group. Gynecol Oncol 1998 0.83
14 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer. Br J Cancer 1999 0.82
15 Pattern of metastases in human breast carcinoma in relation to estrogen receptor status. Anticancer Res 1986 0.81
16 Assessment of patients with metastatic transitional cell carcinoma of the urinary tract. J Urol 1999 0.81
17 Ewing's sarcoma. A retrospective study of prognostic factors and treatment results. Acta Oncol 1987 0.81
18 Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone. Breast Cancer Res Treat 1986 0.81
19 Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age. Breast Cancer Res Treat 2000 0.81
20 Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. J Clin Oncol 1998 0.80
21 A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancer. Gynecol Oncol 1996 0.79
22 Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years. Eur Urol 2001 0.78
23 Intra-uterine exposure to saccharin and risk of bladder cancer in man. Int J Cancer 1982 0.78
24 Ewing's sarcoma. A retrospective study of histological and immunohistochemical factors and their relation to prognosis. Virchows Arch A Pathol Anat Histopathol 1989 0.78
25 Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome. Cancer Genet Cytogenet 2000 0.77
26 Platinum analogue combination chemotherapy: cisplatin, carboplatin, and methotrexate in patients with metastatic urothelial tract tumors. A phase II trial with evaluation of prognostic factors. Cancer 1995 0.77
27 [The pattern of metastases in breast cancer and the relation to estrogen receptor status]. Ugeskr Laeger 1986 0.77
28 Metastatic pattern and response to endocrine therapy in human breast cancer. Breast Cancer Res Treat 1986 0.76
29 Aggressive fibromatosis. Report of two cases with rare clinicopathological manifestations. Arch Orthop Trauma Surg 1986 0.75
30 Differential influence of prognostic factors on the occurrence of metastases at various anatomical sites in human breast cancer. Stat Med 1992 0.75
31 Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method. Bone Marrow Transplant 2002 0.75
32 [Systemic chemotherapy in bladder cancer]. Ugeskr Laeger 1993 0.75
33 [Herceptin (trastuzumab). A new exciting therapeutic principle in breast cancer]. Ugeskr Laeger 2000 0.75
34 Elevated alpha-feto protein in a 51-year-old male with relapsing seminoma, previous hepatitis B and acute hepatitis C. Acta Oncol 1995 0.75
35 [The value of bone marrow scintigraphy in patients with recurrent breast cancer]. Ugeskr Laeger 1993 0.75
36 [Pattern of metastases in breast cancer]. Ugeskr Laeger 1984 0.75
37 The functional and psychosocial status of patients with disseminated bladder cancer. Urol Oncol 2011 0.75
38 Semiparametric Marshall-Olkin models applied to the occurrence of metastases at multiple sites after breast cancer. Biometrics 1989 0.75
39 [Intrauterine exposure to saccharine and risk of cancer of the bladder in man]. Ugeskr Laeger 1982 0.75
40 Systemic mitomycin C as second-line treatment for metastatic urothelial cancer. Acta Oncol 1995 0.75
41 [The significance of prognostic factors on the occurrence of metastases from breast cancer to various localizations]. Ugeskr Laeger 1994 0.75
42 Fine needle aspiration and Tru-Cut biopsy in the diagnosis of soft tissue metastases in breast cancer. Eur J Cancer Clin Oncol 1986 0.75
43 Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer. Acta Oncol 1998 0.75
44 [Diagnosis of the recurrence of soft tissue tumors in breast cancer. Comparison of clinical assessment, Tru-Cut biopsy and repeat fine needle aspiration]. Ugeskr Laeger 1987 0.75